Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Figure Technology Solutions Inc. Class A Common Stock (FIGR) vs Eli Lilly And Co (LLY) Price & Performance

Figure Technology Solutions Inc. Class A Common StockTrade
Eli Lilly And CoTrade

Price performance (Past 24H)

Key statistics

Figure Technology Solutions Inc. Class A Common Stock vs Eli Lilly And Co — how do they compare? Figure Technology Solutions Inc. Class A Common Stock trades at $28.01 (market cap $6.19B), while Eli Lilly And Co trades at $1,167.38 (market cap $1.06T). The key difference: Eli Lilly And Co is far larger — about 171.2× Figure Technology Solutions Inc. Class A Common Stock's market cap, and Eli Lilly And Co pays a 0.58% dividend while Figure Technology Solutions Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Figure Technology Solutions Inc. Class A Common Stock for 0 Days and Eli Lilly And Co for 93 Days on average.

FIGRLLY
Market Cap
$6.19B$1.06T
Volume
4,762,3422,297,239
Sector
FinancialsHealth
52-Week High
$73.91$1.28K
52-Week Low
$24.91$799.57
Typical Hold Time
0 Days93 Days
Enterprise Value
$6.23B$1.11T
Dividend Yield
—0.58%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Figure Technology Solutions Inc. Class A Common Stock

No Aura AI signal available yet.

Eli Lilly And Co

Eli Lilly (LLY) trades at $1,188.72, up 2.7% on the day, with a bullish technical signal and strong fundamentals. Recent earnings beats, robust revenue growth to $65.18B in 2025, and a net income margin of 33.53% highlight operational strength. Positive news flow centers on next-generation weight-loss drugs, with analyst consensus bullish and a price target of $1,350.

Outlook remains positive given pipeline catalysts in obesity/diabetes markets, though high valuations (P/E 39.9) and rising debt levels pose risks. Competitive intensity and regulatory scrutiny are watchpoints, but institutional support and earnings momentum underpin further upside potential.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FIGR
100% Buy0% Sell
Avg holding period · 0 Days
LLY
69% Buy31% Sell
Avg holding period · 93 Days

Top news

Latest headlines on both assets

About Figure Technology Solutions Inc. Class A Common Stock

Figure Technology Solutions operates a blockchain-native capital marketplace. Its platform supports loan origination, funding, sale, and trading of tokenized assets, along with digital-asset infrastructure and services.

Read more on FIGR →

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY →